SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 9 (disorder)
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Obesity
|
0.230 |
Biomarker
|
disease |
CTD_mouse |
Molecular characterization of the mouse agouti locus.
|
1473152 |
1992 |
Malignant Neoplasms
|
0.210 |
Biomarker
|
group |
CTD_mouse |
Molecular characterization of the mouse agouti locus.
|
1473152 |
1992 |
Neoplasms
|
0.210 |
Biomarker
|
group |
CTD_mouse |
Molecular characterization of the mouse agouti locus.
|
1473152 |
1992 |
Diabetes Mellitus
|
0.200 |
Biomarker
|
group |
CTD_mouse |
Molecular characterization of the mouse agouti locus.
|
1473152 |
1992 |
Benign Neoplasm
|
0.200 |
Biomarker
|
group |
CTD_mouse |
Molecular characterization of the mouse agouti locus.
|
1473152 |
1992 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.200 |
Biomarker
|
disease |
MGD |
General survey of diabetic features of yellow KK mice.
|
5468422 |
1970 |
Obesity
|
0.230 |
Biomarker
|
disease |
MGD |
Mutations at the agouti locus in the mouse.
|
5798139 |
1969 |
Maturity onset diabetes mellitus in young
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The localization of ASP relative to other loci on chromosome 20 excludes it as a candidate for the MODY1 locus, a gene responsible for one form of early-onset non-insulin-dependent diabetes mellitus or maturity-onset diabetes of the young.
|
7757071 |
1995 |
Obesity
|
0.230 |
Biomarker
|
disease |
CTD_mouse |
A molecular model for the genetic and phenotypic characteristics of the mouse lethal yellow (Ay) mutation.
|
8146154 |
1994 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.200 |
Biomarker
|
disease |
CTD_mouse |
A molecular model for the genetic and phenotypic characteristics of the mouse lethal yellow (Ay) mutation.
|
8146154 |
1994 |
Incontinentia Pigmenti Achromians
|
0.200 |
Biomarker
|
disease |
CTD_mouse |
A molecular model for the genetic and phenotypic characteristics of the mouse lethal yellow (Ay) mutation.
|
8146154 |
1994 |
Schamberg Disease
|
0.200 |
Biomarker
|
phenotype |
CTD_mouse |
A molecular model for the genetic and phenotypic characteristics of the mouse lethal yellow (Ay) mutation.
|
8146154 |
1994 |
Pigmentation Disorders
|
0.200 |
Biomarker
|
group |
CTD_mouse |
A molecular model for the genetic and phenotypic characteristics of the mouse lethal yellow (Ay) mutation.
|
8146154 |
1994 |
Premature aging syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Extensive fragmentation of mtDNA was detected in association with increased 8-hydroxydeoxyguanosine content in the heart mitochondrial DNA (mtDNA) from a patient with premature aging and mitochondrial cardiomyopathy, who carried a mutation within the mitochondrial tRNA(Asp) gene.
|
8687011 |
1996 |
Mitochondrial cardiomyopathy
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Extensive fragmentation of mtDNA was detected in association with increased 8-hydroxydeoxyguanosine content in the heart mitochondrial DNA (mtDNA) from a patient with premature aging and mitochondrial cardiomyopathy, who carried a mutation within the mitochondrial tRNA(Asp) gene.
|
8687011 |
1996 |
Spinal meningocele
|
0.010 |
Biomarker
|
disease |
BEFREE |
Most frequently the presacral mass in ASP-association was reported to be an anterior meningocele (47%) and a benign teratoma (40%).
|
8740138 |
1996 |
Dermoid Cyst
|
0.010 |
Biomarker
|
disease |
BEFREE |
Most frequently the presacral mass in ASP-association was reported to be an anterior meningocele (47%) and a benign teratoma (40%).
|
8740138 |
1996 |
Meningocele
|
0.010 |
Biomarker
|
disease |
BEFREE |
Most frequently the presacral mass in ASP-association was reported to be an anterior meningocele (47%) and a benign teratoma (40%).
|
8740138 |
1996 |
Congenital meningocele
|
0.010 |
Biomarker
|
disease |
BEFREE |
Most frequently the presacral mass in ASP-association was reported to be an anterior meningocele (47%) and a benign teratoma (40%).
|
8740138 |
1996 |
Benign Teratoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Most frequently the presacral mass in ASP-association was reported to be an anterior meningocele (47%) and a benign teratoma (40%).
|
8740138 |
1996 |
Obesity
|
0.230 |
Biomarker
|
disease |
BEFREE |
Variation in the human counterparts to these genes (OB, DB, TUB, and ASP, respectively) may contribute to human obesity, which is thought to have a substantial genetic component.
|
8772727 |
1996 |
leukemia
|
0.020 |
Biomarker
|
disease |
BEFREE |
The expression was compared between different types of leukemia and was studied in relation with clinical risk indicators and in vitro cytotoxicity of the MDR-related drugs daunorubicin (DNR), vincristine (VCR), and etoposide (VP16) and the non-MDR-related drugs prednisolone (PRD) and L-asparaginase (ASP).
|
9490695 |
1998 |
Childhood Leukemia
|
0.020 |
Biomarker
|
disease |
BEFREE |
The expression was compared between different types of leukemia and was studied in relation with clinical risk indicators and in vitro cytotoxicity of the MDR-related drugs daunorubicin (DNR), vincristine (VCR), and etoposide (VP16) and the non-MDR-related drugs prednisolone (PRD) and L-asparaginase (ASP).
|
9490695 |
1998 |
Antisocial behavior
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
We investigated 56 abstinent patients hypothesizing that four subgroups of abstinent alcoholics with regard to family history (FHP: family history positive, FHN: family history negative) and antisocial behavior (ASP: antisocial traits present, ASN: antisocial traits not present) would exhibit differences in P300, particularly when recorded by frontal electrodes.
|
10085279 |
1999 |